Dispatch Bio Receives FDA Clearance For DISP-10, Immunotherapy
12 Jan 2026 //
BUSINESSWIRE
CARsgen, Dispatch Bio Collaborate On Flare Platform, Zevor-Cel
12 Jan 2026 //
PR NEWSWIRE
Dispatch Bio Introduces Initial Clinical Program & Showcases
04 Nov 2025 //
BUSINESSWIRE
Dispatch Bio Inks Clinical Supply Deal With Bristol Myers Squibb
04 Nov 2025 //
BUSINESSWIRE
Dispatch Bio Names Mauro Avanzi Chief Medical Officer
30 Sep 2025 //
BUSINESSWIRE
Dispatch Bio Debuts Universal Solid Tumors Treatment
23 Jul 2025 //
BUSINESSWIRE

Market Place
Sourcing Support